Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-145,805
Closed -$1.03M 337
2021
Q2
$1.03M Sell
145,805
-37,544
-20% -$285K 0.16% 292
2021
Q1
$1.24M Buy
+183,349
New +$1.06M 0.19% 264
2017
Q1
Sell
-84,609
Closed -$1.19M 345
2016
Q4
$1.19M Sell
84,609
-35,580
-30% -$505K 0.16% 243
2016
Q3
$1.74M Buy
120,189
+36,506
+44% +$555K 0.23% 201
2016
Q2
$1.24M Buy
+83,683
New +$1.04M 0.19% 222
2015
Q2
Sell
-158,694
Closed -$1.66M 348
2015
Q1
$1.66M Buy
158,694
+1,640
+1% +$15.9K 0.19% 218
2014
Q4
$1.34M Sell
157,054
-10,985
-7% -$87K 0.19% 239
2014
Q3
$1.18M Hold
168,039
0.24% 220
2014
Q2
$1.4M Sell
168,039
-1,704
-1% -$14.7K 0.26% 176
2014
Q1
$1.52M Sell
169,743
-4,978
-3% -$45.6K 0.27% 151
2013
Q4
$1.78M Buy
+174,721
New +$1.4M 0.32% 109

Other funds holding IRIX

EAM Investors's IRIX Position: Q3 2021 in Review

EAM Investors sold out of IRIDEX (IRIX) in Q3 2021, closing a stake of 145,805 shares — an estimated $1.03M sold.

EAM Investors first reported a position in IRIX in Q4 2013 and held it in 11 quarters. The position peaked at $1.78M in Q4 2013. 29 funds tracked by Wall St. Rank hold IRIX as of Q3 2021.

  • EAM Investors reported no remaining IRIDEX position as of Q3 2021 after selling out during the quarter.
  • EAM Investors sold 145,805 IRIDEX shares in Q3 2021, an estimated $1.03M.
  • EAM Investors first reported a position in IRIDEX in Q4 2013 and held it in 11 quarters.
  • EAM Investors's IRIDEX position peaked at $1.78M in Q4 2013.
  • 29 funds tracked by Wall St. Rank held IRIDEX as of Q3 2021.

Based on EAM Investors's 13F filing for Q3 2021, filed 12 Nov 2021.